75 related articles for article (PubMed ID: 22462392)
1. Time dependent effect on mortality of drug-eluting stents versus bare metal stents.
Mølstad P
Scand Cardiovasc J; 2012 Aug; 46(4):226-32. PubMed ID: 22462392
[TBL] [Abstract][Full Text] [Related]
2. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
Faxon DP; Lawler E; Young M; Gaziano M; Kinlay S
Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
Jensen LO; Tilsted HH; Thayssen P; Kaltoft A; Maeng M; Lassen JF; Hansen KN; Madsen M; Ravkilde J; Johnsen SP; Sørensen HT; Thuesen L
EuroIntervention; 2010 Apr; 5(8):898-905. PubMed ID: 20542774
[TBL] [Abstract][Full Text] [Related]
5. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries).
Cheng JM; Onuma Y; Piazza N; Nuis RJ; Van Domburg RT; Serruys PW;
Am J Cardiol; 2010 Nov; 106(10):1376-81. PubMed ID: 21059424
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.
Lagerqvist B; James SK; Stenestrand U; Lindbäck J; Nilsson T; Wallentin L;
N Engl J Med; 2007 Mar; 356(10):1009-19. PubMed ID: 17296822
[TBL] [Abstract][Full Text] [Related]
7. Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions.
Assali A; Vaduganathan M; Vaknin-Assa H; Lev EI; Brosh D; Teplitsky I; Bental T; Battler A; Kornowski R
Am J Cardiol; 2012 Jun; 109(11):1563-8. PubMed ID: 22440117
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of major clinical outcomes with drug-eluting stents versus bare metal stents in male versus female patients.
Kornowski R; Vaknin-Assa H; Assali A; Lev EI; Porter A; Battler A; Bental T
EuroIntervention; 2012 Jan; 7(9):1051-9. PubMed ID: 22207229
[TBL] [Abstract][Full Text] [Related]
9. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
[TBL] [Abstract][Full Text] [Related]
10. Long-term paclitaxel-eluting stent outcomes in elderly patients.
Forman DE; Cox DA; Ellis SG; Lasala JM; Ormiston JA; Stone GW; Turco MA; Wei JY; Joshi AA; Dawkins KD; Baim DS
Circ Cardiovasc Interv; 2009 Jun; 2(3):178-87. PubMed ID: 20031714
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting stents versus bare-metal stents for off-label indications: a propensity score-matched outcome study.
Austin D; Oldroyd KG; McConnachie A; Slack R; Eteiba H; Flapan AD; Jennings KP; Northcote RJ; Pell AC; Starkey IR; Pell JP
Circ Cardiovasc Interv; 2008 Aug; 1(1):45-52. PubMed ID: 20031654
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis.
Singh IM; Filby SJ; Sakr FE; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH
Catheter Cardiovasc Interv; 2010 Feb; 75(3):338-42. PubMed ID: 19937786
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.
James SK; Stenestrand U; Lindbäck J; Carlsson J; Scherstén F; Nilsson T; Wallentin L; Lagerqvist B;
N Engl J Med; 2009 May; 360(19):1933-45. PubMed ID: 19420363
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients.
Chiu M; Ko DT; Austin PC; Cohen EA; Velianou JL; Goeree R; Blackhouse G; Tu JV
Circ Cardiovasc Qual Outcomes; 2009 Mar; 2(2):96-107. PubMed ID: 20031821
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes after coronary bare-metal-stent and drug-eluting-stent implantations: a 'real-world' comparison among patients with diabetes with diffuse small vessel coronary artery disease.
Koh AS; Chia S; Choi LM; Sim LL; Chua TS; Koh TH; Tan JW
Coron Artery Dis; 2011 Mar; 22(1):96-9. PubMed ID: 21164343
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of diabetics receiving bare-metal stents versus drug-eluting stents.
Ramanath VS; Brown JR; Malenka DJ; DeVries JT; Sidhu MS; Robb JF; Jayne JE; Hettleman BD; Friedman BJ; Niles NW; Kaplan AV; Thompson CA;
Catheter Cardiovasc Interv; 2010 Oct; 76(4):473-81. PubMed ID: 20882647
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.
Varani E; Guastaroba P; Di Tanna GL; Saia F; Balducelli M; Campo G; Vignali L; Rossi R; Manari A; Piovaccari G; De Palma R; Marzocchi A
EuroIntervention; 2010 Apr; 5(8):953-61. PubMed ID: 20542781
[TBL] [Abstract][Full Text] [Related]
20. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
